AF
IDXX icon

Avanza Fonder’s Idexx Laboratories IDXX Stock Holding History

Avanza Fonder’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Sell
5,175
-1,752
-25% -$983K 0.06% 242
2026
Q1 		$3.89M Buy
6,927
+353
+5% +$226K 0.11% 179
2025
Q4 		$4.45M Buy
6,574
+1,078
+20% +$734K 0.11% 165
2025
Q3 		$3.51M Hold
5,496
– – 0.09% 178
2025
Q2 		$2.95M Hold
5,496
– – 0.09% 189
2025
Q1 		$2.34M Sell
5,496
-1,006
-15% -$437K 0.08% 217
2024
Q4 		$2.69M Buy
+6,502
New +$2.85M 0.08% 200

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Avanza Fonder's IDXX Position: Q2 2026 in Review

Avanza Fonder reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $983K and leaving 5,175 shares worth $2.72M. The position accounts for 0.06% of the portfolio, ranked #242.

Avanza Fonder first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.45M in Q4 2025. 416 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Avanza Fonder held 5,175 shares of Idexx Laboratories worth $2.72M as of Q2 2026.
  • Avanza Fonder sold 1,752 Idexx Laboratories shares in Q2 2026, an estimated $983K.
  • Idexx Laboratories made up 0.06% of Avanza Fonder's portfolio in Q2 2026, its #242 holding.
  • Avanza Fonder first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Idexx Laboratories position peaked at $4.45M in Q4 2025.
  • 416 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.